Bass, Berry & Sims served as lead counsel representing an emergency department provider and other defendants in a qui tam lawsuit alleging that violation of licensure laws caused submission of false claims. The district court dismissed the allegations against the emergency department provider on the grounds that the alleged regulatory violation did not satisfy standard for FCA materiality set forth in Supreme Court’s Escobar decision. U.S. ex rel. Taylor v. Boyko, 2019 WL 2423283 (S.D. W. Va. Jun. 6, 2019).
U.S. ex rel. Taylor v. Boyko, M.D. et al.
You Also May Be Interested In:
We represented BioScrip, Inc. in its merger with Option Care Enterprises, Inc. The newly combined company, Option Care Health, Inc., emerges as the largest independent home and alternate site infusion services provider in the United States. Option Care Health’s common stock will be listed on the Nasdaq Global Select Market under the ticker symbol BIOS.
Served as lead counsel to BriovaRx Infusion Services in obtaining a Certificate of Need to expand services in Middle Tennessee